Return On Equity of BridgeBio Oncology Therapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BridgeBio Oncology Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • BridgeBio Oncology Therapeutics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -125%, a 356% decline year-over-year.
  • BridgeBio Oncology Therapeutics, Inc. annual Return On Equity for 2025 was -125%, a 356% decline from 2024.
  • BridgeBio Oncology Therapeutics, Inc. annual Return On Equity for 2024 was 49%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

BridgeBio Oncology Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -125% -173% -356% 01 Oct 2025 31 Dec 2025
Q3 2025 288% 01 Jul 2025 30 Sep 2025
Q2 2025 46% 01 Apr 2025 30 Jun 2025
Q1 2025 47% 01 Jan 2025 31 Mar 2025
Q4 2024 49% 01 Oct 2024 31 Dec 2024

BridgeBio Oncology Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -125% -173% -356% 01 Jan 2025 31 Dec 2025
2024 49% +49% 01 Jan 2024 31 Dec 2024
2023 0.14%* 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.